Skip to content

STARBEAM-X: Assessing blood flow in brain tumors using MRI before and after targeted radiation treatment

Dynamic susceptibility contrast MRI Perfusion assessment of brain metastases: baseline characteristics and the study of pattern of perfusion change in suspected radionecrosis post-stereotactic radiosurgery (STARBEAM-X)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN62305334
Enrollment
40
Registered
2023-02-27
Start date
2022-05-09
Completion date
Unknown
Last updated
2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain cancer Cancer

Interventions

When the patient attends for their radiotherapy planning MRI scan, they will undergo the conventional imaging sequences as per the standard of care and, during this scan, they will also undergo additi

Sponsors

Newcastle upon Tyne Hospitals NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age of 18 years or above on the day of recruitment 2. Have one or more brain metastases from an extracranial primary solid malignancy 3. Accepted for stereotactic radiosurgery to one or more brain metastases following discussion at the local SRS MDT 4. Must have never received any form of prior radiotherapy to the brain

Exclusion criteria

Exclusion criteria: 1. Age < 18 years old at the time of eligibility screening 2. Patient has received prior radiotherapy to the brain

Design outcomes

Primary

MeasureTime frame
1. Baseline perfusion characteristics of host cerebral vascular environment (measured in rCBV on MRI) 2. Baseline perfusion characteristics of brain metastases from a selection of primary sites (measured in rCBV on MRI)

Secondary

MeasureTime frame
1. Correlation between baseline perfusion characteristics of brain metastases and primary site of malignancy (descriptive stats – correlation coefficient) 2. Inter-tumour variability in baseline perfusion characteristics in patients with more than one brain metastasis (descriptive stats) Exploratory: 3. To identify patients with suspected radionecrosis during data collection phase 1 and analyse baseline perfusion characteristics with a view to identifying possible risk associations – measured in follow-up period up to 2 years (descriptive)

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026